DOI: 10.1016/s0022-2143(96)90035-9. Amplification of antibody production by phosphorothioate oligodeoxynucleotides

Amplification of antibody production by phosphorothioate oligodeoxynucleotides

10.1016/s0022-2143(96)90035-9

Crossref journal-article

Elsevier BV

Journal of Laboratory and Clinical Medicine (78)

Bibliography

Branda, R. F., Moore, A. L., Lafayette, A. R., Mathews, L., Hong, R., Zon, G., Brown, T., & McCormack, J. J. (1996). Amplification of antibody production by phosphorothioate oligodeoxynucleotides. Journal of Laboratory and Clinical Medicine, 128(3), 329â338.

Authors 8

Richard F Branda (first)
Ann L Moore (additional)
Amy R Lafayette (additional)
Linda Mathews (additional)
Richard Hong (additional)
Gerald Zon (additional)
Thomas Brown (additional)
John J McCormack (additional)

References 30 Referenced 39

10.1016/0163-7258(91)90009-B / Pharmacol Ther / Oligonucleotides as therapeutic agents by Cohen (1991)
10.1038/372333a0 / Nature / Gene inhibition using antisense oligodeoxynucleotides by Wagner (1994)
10.1016/S0021-9258(17)33991-1 / J Biol Chem / Short antisense oligonucleotide-mediated inhibition is strongly dependent on oligo length and concentration but almost independent of location of the target sequence by Fakler (1994)
10.7326/0003-4819-120-2-199401150-00010 / Ann Intern Med / Antisense oligonucleotide therapies: are they the “magic bullets” by Ma (1994)
10.1111/j.1365-2141.1994.tb08296.x / Br J Haematol / Antisense therapeutics in haematological malignancies by Kirkland (1994)
{'key': '10.1016/S0022-2143(96)90035-9_BIB6', 'series-title': 'Is the bullet really magical?', 'first-page': '1004', 'article-title': 'Antisense oligonucleotides as therapeutic agents', 'volume': '261', 'author': 'Stein', 'year': '1993'} / Is the bullet really magical? / Antisense oligonucleotides as therapeutic agents by Stein (1993)
10.1016/0006-2952(93)90014-N / Biochem Pharmacol / Immune stimulation by an antisense oligomer which is complementary to the rev gene of HIV-1 by Branda (1993)
{'key': '10.1016/S0022-2143(96)90035-9_BIB8', 'first-page': '455', 'article-title': 'Stimulation of peripheral blood mononuclear cells (PBMNCs) from chronic lymphatic leukemia (CLL) patients by an antisense phosphorothioate oligomer to the rev gene of HIV [abstract]', 'volume': '34', 'author': 'Branda', 'year': '1993'} / Stimulation of peripheral blood mononuclear cells (PBMNCs) from chronic lymphatic leukemia (CLL) patients by an antisense phosphorothioate oligomer to the rev gene of HIV [abstract] by Branda (1993)
10.1006/clin.1996.0058 / Clin Immunol Immunopathol / B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1 by Branda (1996)
{'key': '10.1016/S0022-2143(96)90035-9_BIB10', 'first-page': '552', 'article-title': 'Specific in vivo and in vitro antibody response to tetanus toxoid immunization', 'volume': '49', 'author': 'Ershler', 'year': '1982', 'journal-title': 'Clin Exp Immunol'} / Clin Exp Immunol / Specific in vivo and in vitro antibody response to tetanus toxoid immunization by Ershler (1982)
{'key': '10.1016/S0022-2143(96)90035-9_BIB11', 'first-page': '296', 'article-title': 'Statistical principles in experimental design', 'author': 'Winer', 'year': '1971'} / Statistical principles in experimental design by Winer (1971)
10.1038/374546a0 / Nature / CpG motifs in baterial DNA trigger direct B-cell activation by Krieg (1995)
10.4049/jimmunol.140.7.2431 / J Immunol / Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes by Harel-Bellan (1988)
10.1126/science.2237430 / Science / cdc2 gene expression at the G1 to S transition in human T lymphocytes by Furukawa (1990)
10.1126/science.2665077 / Science / G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb by Gewirtz (1989)
10.1111/j.1365-3083.1994.tb03405.x / Scand J Immunol / Antisense oligodeoxynucleotides for IL-2, c-myc, and transferrin receptor synchronize mitogen-activated lymphocytes in the G1 phase by Kato (1994)
10.1084/jem.175.2.597 / J Exp Med / An antisense oligonucleotide complementary to a sequence in Iγ2b increases y2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion by Tanaka (1992)
10.1006/clin.1993.1055 / Clin Immunol Immunopathol / Administration of a phosporothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner by Mojcik (1993)
10.4049/jimmunol.143.8.2448 / J Immunol / A role for endogenous retroviral sequences in the regulation of lymphocyte activation by Krieg (1989)
10.1089/ard.1993.3.309 / Antisense Res Dev / A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kB p65 causes sequence-specific immune stimulation by McIntyre (1993)
10.1016/0006-2952(95)02177-9 / Biochem Pharmacol / Effect of different chemically modified oligodeoxynucleotides on immune stimulation by Zhao (1996)
{'key': '10.1016/S0022-2143(96)90035-9_BIB22', 'first-page': '4051', 'article-title': 'The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism', 'volume': '92', 'author': 'Burgess', 'year': '1995'} / The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism by Burgess (1995)
10.1089/ard.1993.3.67 / Antisense Res Dev / Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells by Yaswen (1993)
10.1093/nar/23.7.1146 / Nucleic Acids Res / Sequence context of antisense ReIA/NF-kB phosphorothioates determines specificity by Maltese (1995)
{'key': '10.1016/S0022-2143(96)90035-9_BIB25', 'first-page': '63', 'article-title': 'The inducible transcription activator NF-kB: regulation by distinct protein subunits', 'volume': '1072', 'author': 'Baeuerle', 'year': '1991', 'journal-title': 'Biochim Biophys Acta'} / Biochim Biophys Acta / The inducible transcription activator NF-kB: regulation by distinct protein subunits by Baeuerle (1991)
10.1146/annurev.iy.12.040194.001041 / Annu Rev Immunol / Function and activation of NF-kB in the immune system by Baeuerle (1994)
10.1016/0024-3205(94)00780-2 / Life Sci / Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus by Pisetsky (1994)
{'key': '10.1016/S0022-2143(96)90035-9_BIB28', 'first-page': '523', 'article-title': 'Toxicity of human p53 antisense oligonucleotide infusions in Rhesus macacca', 'volume': '33', 'author': 'Spinolo', 'year': '1992'} / Toxicity of human p53 antisense oligonucleotide infusions in Rhesus macacca by Spinolo (1992)
{'key': '10.1016/S0022-2143(96)90035-9_BIB29', 'first-page': '522', 'article-title': 'Systemic human p53 antisense oligonucleotide in Rhesus monkey', 'volume': '33', 'author': 'Iversen', 'year': '1992'} / Systemic human p53 antisense oligonucleotide in Rhesus monkey by Iversen (1992)
{'issue': 'suppl 1', 'key': '10.1016/S0022-2143(96)90035-9_BIB30', 'first-page': '443a', 'article-title': 'Phase I trial of systemic administration of ol(1)p53 oligonucleotide in refractory acute myelogenous leukemia and advanced myeloysplastic syndrome [abstract]', 'volume': '82', 'author': 'Bishop', 'year': '1993', 'journal-title': 'Blood'} / Blood / Phase I trial of systemic administration of ol(1)p53 oligonucleotide in refractory acute myelogenous leukemia and advanced myeloysplastic syndrome [abstract] by Bishop (1993)

Dates

Type	When
Created	21 years, 1 month ago (July 7, 2004, 2:52 p.m.)
Deposited	2 years, 4 months ago (April 28, 2023, 7:21 p.m.)
Indexed	1 year, 10 months ago (Oct. 17, 2023, 5:34 p.m.)
Issued	29 years ago (Sept. 1, 1996)
Published	29 years ago (Sept. 1, 1996)
Published Print	29 years ago (Sept. 1, 1996)

Funders 0

None

BibTeX

@article{Branda_1996, title={Amplification of antibody production by phosphorothioate oligodeoxynucleotides}, volume={128}, ISSN={0022-2143}, url={http://dx.doi.org/10.1016/s0022-2143(96)90035-9}, DOI={10.1016/s0022-2143(96)90035-9}, number={3}, journal={Journal of Laboratory and Clinical Medicine}, publisher={Elsevier BV}, author={Branda, Richard F and Moore, Ann L and Lafayette, Amy R and Mathews, Linda and Hong, Richard and Zon, Gerald and Brown, Thomas and McCormack, John J}, year={1996}, month=sep, pages={329–338} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        17
      ]
    ],
    "date-time": "2023-10-17T21:34:33Z",
    "timestamp": 1697578473201
  },
  "reference-count": 30,
  "publisher": "Elsevier BV",
  "issue": "3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1996,
            9,
            1
          ]
        ],
        "date-time": "1996-09-01T00:00:00Z",
        "timestamp": 841536000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1996,
        9
      ]
    ]
  },
  "DOI": "10.1016/s0022-2143(96)90035-9",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        7,
        7
      ]
    ],
    "date-time": "2004-07-07T18:52:32Z",
    "timestamp": 1089226352000
  },
  "page": "329-338",
  "source": "Crossref",
  "is-referenced-by-count": 39,
  "title": "Amplification of antibody production by phosphorothioate oligodeoxynucleotides",
  "prefix": "10.1016",
  "volume": "128",
  "author": [
    {
      "given": "Richard F",
      "family": "Branda",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Ann L",
      "family": "Moore",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Amy R",
      "family": "Lafayette",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Linda",
      "family": "Mathews",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Richard",
      "family": "Hong",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Gerald",
      "family": "Zon",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Thomas",
      "family": "Brown",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "John J",
      "family": "McCormack",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "DOI": "10.1016/0163-7258(91)90009-B",
      "article-title": "Oligonucleotides as therapeutic agents",
      "volume": "52",
      "author": "Cohen",
      "year": "1991",
      "journal-title": "Pharmacol Ther"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "333",
      "DOI": "10.1038/372333a0",
      "article-title": "Gene inhibition using antisense oligodeoxynucleotides",
      "volume": "372",
      "author": "Wagner",
      "year": "1994",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "16187",
      "DOI": "10.1016/S0021-9258(17)33991-1",
      "article-title": "Short antisense oligonucleotide-mediated inhibition is strongly dependent on oligo length and concentration but almost independent of location of the target sequence",
      "volume": "269",
      "author": "Fakler",
      "year": "1994",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "DOI": "10.7326/0003-4819-120-2-199401150-00010",
      "article-title": "Antisense oligonucleotide therapies: are they the \u201cmagic bullets\u201d",
      "volume": "120",
      "author": "Ma",
      "year": "1994",
      "journal-title": "Ann Intern Med"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "447",
      "DOI": "10.1111/j.1365-2141.1994.tb08296.x",
      "article-title": "Antisense therapeutics in haematological malignancies",
      "volume": "87",
      "author": "Kirkland",
      "year": "1994",
      "journal-title": "Br J Haematol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB6",
      "series-title": "Is the bullet really magical?",
      "first-page": "1004",
      "article-title": "Antisense oligonucleotides as therapeutic agents",
      "volume": "261",
      "author": "Stein",
      "year": "1993"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "2037",
      "DOI": "10.1016/0006-2952(93)90014-N",
      "article-title": "Immune stimulation by an antisense oligomer which is complementary to the rev gene of HIV-1",
      "volume": "45",
      "author": "Branda",
      "year": "1993",
      "journal-title": "Biochem Pharmacol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB8",
      "first-page": "455",
      "article-title": "Stimulation of peripheral blood mononuclear cells (PBMNCs) from chronic lymphatic leukemia (CLL) patients by an antisense phosphorothioate oligomer to the rev gene of HIV [abstract]",
      "volume": "34",
      "author": "Branda",
      "year": "1993"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "DOI": "10.1006/clin.1996.0058",
      "article-title": "B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1",
      "volume": "79",
      "author": "Branda",
      "year": "1996",
      "journal-title": "Clin Immunol Immunopathol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB10",
      "first-page": "552",
      "article-title": "Specific in vivo and in vitro antibody response to tetanus toxoid immunization",
      "volume": "49",
      "author": "Ershler",
      "year": "1982",
      "journal-title": "Clin Exp Immunol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB11",
      "first-page": "296",
      "article-title": "Statistical principles in experimental design",
      "author": "Winer",
      "year": "1971"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "546",
      "DOI": "10.1038/374546a0",
      "article-title": "CpG motifs in baterial DNA trigger direct B-cell activation",
      "volume": "374",
      "author": "Krieg",
      "year": "1995",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "2431",
      "DOI": "10.4049/jimmunol.140.7.2431",
      "article-title": "Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes",
      "volume": "140",
      "author": "Harel-Bellan",
      "year": "1988",
      "journal-title": "J Immunol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "805",
      "DOI": "10.1126/science.2237430",
      "article-title": "cdc2 gene expression at the G1 to S transition in human T lymphocytes",
      "volume": "250",
      "author": "Furukawa",
      "year": "1990",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "180",
      "DOI": "10.1126/science.2665077",
      "article-title": "G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb",
      "volume": "245",
      "author": "Gewirtz",
      "year": "1989",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "499",
      "DOI": "10.1111/j.1365-3083.1994.tb03405.x",
      "article-title": "Antisense oligodeoxynucleotides for IL-2, c-myc, and transferrin receptor synchronize mitogen-activated lymphocytes in the G1 phase",
      "volume": "39",
      "author": "Kato",
      "year": "1994",
      "journal-title": "Scand J Immunol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB17",
      "doi-asserted-by": "crossref",
      "first-page": "597",
      "DOI": "10.1084/jem.175.2.597",
      "article-title": "An antisense oligonucleotide complementary to a sequence in I\u03b32b increases y2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion",
      "volume": "175",
      "author": "Tanaka",
      "year": "1992",
      "journal-title": "J Exp Med"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "130",
      "DOI": "10.1006/clin.1993.1055",
      "article-title": "Administration of a phosporothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner",
      "volume": "67",
      "author": "Mojcik",
      "year": "1993",
      "journal-title": "Clin Immunol Immunopathol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "2448",
      "DOI": "10.4049/jimmunol.143.8.2448",
      "article-title": "A role for endogenous retroviral sequences in the regulation of lymphocyte activation",
      "volume": "143",
      "author": "Krieg",
      "year": "1989",
      "journal-title": "J Immunol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "DOI": "10.1089/ard.1993.3.309",
      "article-title": "A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kB p65 causes sequence-specific immune stimulation",
      "volume": "3",
      "author": "McIntyre",
      "year": "1993",
      "journal-title": "Antisense Res Dev"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB21",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "DOI": "10.1016/0006-2952(95)02177-9",
      "article-title": "Effect of different chemically modified oligodeoxynucleotides on immune stimulation",
      "volume": "51",
      "author": "Zhao",
      "year": "1996",
      "journal-title": "Biochem Pharmacol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB22",
      "first-page": "4051",
      "article-title": "The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism",
      "volume": "92",
      "author": "Burgess",
      "year": "1995"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "67",
      "DOI": "10.1089/ard.1993.3.67",
      "article-title": "Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells",
      "volume": "3",
      "author": "Yaswen",
      "year": "1993",
      "journal-title": "Antisense Res Dev"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "1146",
      "DOI": "10.1093/nar/23.7.1146",
      "article-title": "Sequence context of antisense ReIA/NF-kB phosphorothioates determines specificity",
      "volume": "23",
      "author": "Maltese",
      "year": "1995",
      "journal-title": "Nucleic Acids Res"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB25",
      "first-page": "63",
      "article-title": "The inducible transcription activator NF-kB: regulation by distinct protein subunits",
      "volume": "1072",
      "author": "Baeuerle",
      "year": "1991",
      "journal-title": "Biochim Biophys Acta"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "141",
      "DOI": "10.1146/annurev.iy.12.040194.001041",
      "article-title": "Function and activation of NF-kB in the immune system",
      "volume": "12",
      "author": "Baeuerle",
      "year": "1994",
      "journal-title": "Annu Rev Immunol"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.1016/0024-3205(94)00780-2",
      "article-title": "Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus",
      "volume": "54",
      "author": "Pisetsky",
      "year": "1994",
      "journal-title": "Life Sci"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB28",
      "first-page": "523",
      "article-title": "Toxicity of human p53 antisense oligonucleotide infusions in Rhesus macacca",
      "volume": "33",
      "author": "Spinolo",
      "year": "1992"
    },
    {
      "key": "10.1016/S0022-2143(96)90035-9_BIB29",
      "first-page": "522",
      "article-title": "Systemic human p53 antisense oligonucleotide in Rhesus monkey",
      "volume": "33",
      "author": "Iversen",
      "year": "1992"
    },
    {
      "issue": "suppl 1",
      "key": "10.1016/S0022-2143(96)90035-9_BIB30",
      "first-page": "443a",
      "article-title": "Phase I trial of systemic administration of ol(1)p53 oligonucleotide in refractory acute myelogenous leukemia and advanced myeloysplastic syndrome [abstract]",
      "volume": "82",
      "author": "Bishop",
      "year": "1993",
      "journal-title": "Blood"
    }
  ],
  "container-title": "Journal of Laboratory and Clinical Medicine",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0022214396900359?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0022214396900359?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        28
      ]
    ],
    "date-time": "2023-04-28T23:21:45Z",
    "timestamp": 1682724105000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0022214396900359"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1996,
        9
      ]
    ]
  },
  "references-count": 30,
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          1996,
          9
        ]
      ]
    }
  },
  "alternative-id": [
    "S0022214396900359"
  ],
  "URL": "http://dx.doi.org/10.1016/S0022-2143(96)90035-9",
  "relation": {},
  "ISSN": [
    "0022-2143"
  ],
  "subject": [],
  "container-title-short": "Journal of Laboratory and Clinical Medicine",
  "published": {
    "date-parts": [
      [
        1996,
        9
      ]
    ]
  }
}